Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS in Subjects with Lupus Nephritis Biotech Investing
U.S. Food and Drug Administration Approves Opdivo® as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy Biotech Investing
Wellteq Management Webcast on May 25, 2021 Chief Medical Officer - Dr. George Gellert Biotech Investing
Lexaria's Newest DehydraTECH 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever Biotech Investing
Lexaria's Newest DehydraTECH 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever Biotech Investing
Bristol Myers Squibb Elects Manuel Hidalgo Medina, M.D., Ph.D. to Board of Directors Biotech Investing
Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021 Biotech Investing
